Annual Total Liabilities
$96.16 M
+$14.62 M+17.94%
31 December 2023
Summary:
X4 Pharmaceuticals annual total liabilities is currently $96.16 million, with the most recent change of +$14.62 million (+17.94%) on 31 December 2023. During the last 3 years, it has risen by +$46.09 million (+92.04%). XFOR annual total liabilities is now at all-time high.XFOR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$118.54 M
+$2.38 M+2.05%
30 September 2024
Summary:
X4 Pharmaceuticals quarterly total liabilities is currently $118.54 million, with the most recent change of +$2.38 million (+2.05%) on 30 September 2024. Over the past year, it has increased by +$12.85 million (+12.15%). XFOR quarterly total liabilities is now at all-time high.XFOR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XFOR Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.9% | +12.2% |
| 3 y3 years | +92.0% | +128.7% |
| 5 y5 years | +567.6% | +289.6% |
XFOR Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +92.0% | at high | +137.5% |
| 5 y | 5 years | at high | +567.6% | at high | +289.6% |
| alltime | all time | at high | +567.6% | at high | +723.0% |
X4 Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $118.54 M(+2.1%) |
| June 2024 | - | $116.16 M(+4.5%) |
| Mar 2024 | - | $111.15 M(+15.6%) |
| Dec 2023 | $96.16 M(+17.9%) | $96.16 M(-9.0%) |
| Sept 2023 | - | $105.70 M(-0.2%) |
| June 2023 | - | $105.86 M(+45.6%) |
| Mar 2023 | - | $72.73 M(-10.8%) |
| Dec 2022 | $81.53 M(+54.5%) | $81.53 M(+58.1%) |
| Sept 2022 | - | $51.56 M(+1.2%) |
| June 2022 | - | $50.95 M(+2.1%) |
| Mar 2022 | - | $49.91 M(-5.4%) |
| Dec 2021 | $52.76 M(+5.4%) | $52.76 M(+1.8%) |
| Sept 2021 | - | $51.84 M(-1.2%) |
| June 2021 | - | $52.45 M(-3.1%) |
| Mar 2021 | - | $54.10 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $50.07 M(+59.1%) | $50.07 M(+15.3%) |
| Sept 2020 | - | $43.42 M(+15.3%) |
| June 2020 | - | $37.65 M(+7.8%) |
| Mar 2020 | - | $34.93 M(+11.0%) |
| Dec 2019 | $31.48 M(+118.5%) | $31.48 M(+3.4%) |
| Sept 2019 | - | $30.43 M(-18.5%) |
| June 2019 | - | $37.34 M(+12.8%) |
| Mar 2019 | - | $33.11 M(+129.9%) |
| Dec 2018 | $14.40 M(-36.1%) | $14.40 M(-20.0%) |
| Sept 2018 | - | $18.00 M(-7.4%) |
| June 2018 | - | $19.45 M(-6.5%) |
| Mar 2018 | - | $20.80 M(-7.8%) |
| Dec 2017 | $22.55 M(-64.9%) | $22.55 M(-11.8%) |
| Sept 2017 | - | $25.56 M(-60.2%) |
| Dec 2016 | $64.17 M(+46.4%) | $64.17 M |
| Dec 2015 | $43.83 M | - |
FAQ
- What is X4 Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals annual total liabilities year-on-year change?
- What is X4 Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly total liabilities year-on-year change?
What is X4 Pharmaceuticals annual total liabilities?
The current annual total liabilities of XFOR is $96.16 M
What is the all time high annual total liabilities for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual total liabilities is $96.16 M
What is X4 Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, XFOR annual total liabilities has changed by +$14.62 M (+17.94%)
What is X4 Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of XFOR is $118.54 M
What is the all time high quarterly total liabilities for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly total liabilities is $118.54 M
What is X4 Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, XFOR quarterly total liabilities has changed by +$12.85 M (+12.15%)